The pharma company, which was founded in 2007 have developed a new chewing gum, Fostrap, which could help the sufferers of kidney disease. The chewing gum works by removing high levels of phosphate from kidney disease patients which is collected in the saliva as they chew the gum.
The pharmaceutical company also makes products for those with intestinal pain and colon cancer.
Luis Cantarell, president and chief executive of Nestle Health Science, said: “This acquisition is an excellent fit with Nestle Health Sciences strategic goal of being a pioneer in the promising area of science-based nutrition.”
Are you looking for a new position in the pharmaceutical industry? Click here to search our current pharma jobs online now.